FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

R Boellaard, R Delgado-Bolton, WJG Oyen… - European journal of …, 2015 - Springer
The purpose of these guidelines is to assist physicians in recommending, performing,
interpreting and reporting the results of FDG PET/CT for oncological imaging of adult …

From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors

RL Wahl, H Jacene, Y Kasamon… - Journal of nuclear …, 2009 - Soc Nuclear Med
The purpose of this article is to review the status and limitations of anatomic tumor response
metrics including the World Health Organization (WHO) criteria, the Response Evaluation …

Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice …

N Ramnath, TJ Dilling, LJ Harris, AW Kim, GC Michaud… - Chest, 2013 - Elsevier
Objectives Stage III non-small cell lung cancer (NSCLC) describes a heterogeneous
population with disease presentation ranging from apparently resectable tumors with occult …

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0

R Boellaard, MJ O'Doherty, WA Weber… - European journal of …, 2010 - Springer
The aim of this guideline is to provide a minimum standard for the acquisition and
interpretation of PET and PET/CT scans with [18F]-fluorodeoxyglucose (FDG). This guideline …

Standards for PET image acquisition and quantitative data analysis

R Boellaard - Journal of nuclear medicine, 2009 - Soc Nuclear Med
Quantitative 18 F-FDG PET is increasingly being recognized as an important tool for
diagnosis, determination of prognosis, and response monitoring in oncology. However, PET …

Molecular imaging in drug development

JK Willmann, N Van Bruggen, LM Dinkelborg… - Nature reviews Drug …, 2008 - nature.com
Molecular imaging can allow the non-invasive assessment of biological and biochemical
processes in living subjects. Such technologies therefore have the potential to enhance our …

Predicting outcomes in radiation oncology—multifactorial decision support systems

P Lambin, RGPM Van Stiphout… - Nature reviews Clinical …, 2013 - nature.com
With the emergence of individualized medicine and the increasing amount and complexity of
available medical data, a growing need exists for the development of clinical decision …

Positron emission tomography (PET) in oncology

A Gallamini, C Zwarthoed, A Borra - Cancers, 2014 - mdpi.com
Since its introduction in the early nineties as a promising functional imaging technique in the
management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has …

18F-FDG PET and PET/CT in the evaluation of cancer treatment response

S Ben-Haim, P Ell - Journal of Nuclear Medicine, 2009 - Soc Nuclear Med
Multimodality imaging, as represented by its greatest exponent, PET/CT, has a firm place in
the evaluation of a patient presenting with cancer. With 18F-FDG, PET/CT is rapidly …

Feasibility of state of the art PET/CT systems performance harmonisation

A Kaalep, T Sera, S Rijnsdorp, M Yaqub… - European journal of …, 2018 - Springer
Purpose The objective of this study was to explore the feasibility of harmonising
performance for PET/CT systems equipped with time-of-flight (ToF) and resolution …